Single-cell analysis,
built for the clinic.
Traditional bulk sequencing flattens complexity. We resolve it cell by cell. Using FFPE or frozen samples, our proprietary platform delivers high-quality single-cell maps and clinician-ready reports in less than two weeks. Backed by AI, validated across multiple tumor types and designed for real-world use, we are making single-cell data clinically usable.
